334 related articles for article (PubMed ID: 32084065)
1. Melatonin, Ramelteon, Suvorexant, and Dexmedetomidine to Promote Sleep and Prevent Delirium in Critically Ill Patients: A Narrative Review With Practical Applications.
Fontaine GV; Der Nigoghossian C; Hamilton LA
Crit Care Nurs Q; 2020; 43(2):232-250. PubMed ID: 32084065
[TBL] [Abstract][Full Text] [Related]
2. Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients.
Kawada K; Ohta T; Tanaka K; Miyamura M; Tanaka S
J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):142-148. PubMed ID: 30322756
[TBL] [Abstract][Full Text] [Related]
3. Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients.
Mo Y; Scheer CE; Abdallah GT
J Intensive Care Med; 2016 Aug; 31(7):451-5. PubMed ID: 26092575
[TBL] [Abstract][Full Text] [Related]
4. Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk Factors.
Hatta K; Kishi Y; Wada K; Takeuchi T; Hashimoto N; Suda K; Taira T; Tsuchida K; Ohmori T; Akizuki N; Nishio Y; Nakanishi Y; Usui C; Kurata A; Horikawa N; Eguchi H; Ito S; Muto H; Nakamura H; Uchimura N
J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31851436
[TBL] [Abstract][Full Text] [Related]
5. Potential use of melatonin in sleep and delirium in the critically ill.
Bellapart J; Boots R
Br J Anaesth; 2012 Apr; 108(4):572-80. PubMed ID: 22419624
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial.
Martinez FE; Anstey M; Ford A; Roberts B; Hardie M; Palmer R; Choo L; Hillman D; Hensley M; Kelty E; Murray K; Singh B; Wibrow B
Trials; 2017 Jan; 18(1):4. PubMed ID: 28061873
[TBL] [Abstract][Full Text] [Related]
7. The role of melatonin and melatonin receptor agonist in the prevention of sleep disturbances and delirium in intensive care unit - a clinical review.
Lewandowska K; Małkiewicz MA; Siemiński M; Cubała WJ; Winklewski PJ; Mędrzycka-Dąbrowska WA
Sleep Med; 2020 May; 69():127-134. PubMed ID: 32074506
[TBL] [Abstract][Full Text] [Related]
8. COVID-19-Associated Hyperactive Intensive Care Unit Delirium With Proposed Pathophysiology and Treatment: A Case Report.
Sher Y; Rabkin B; Maldonado JR; Mohabir P
Psychosomatics; 2020; 61(5):544-550. PubMed ID: 32591212
[No Abstract] [Full Text] [Related]
9. Evaluation of Delirium in Critically Ill Patients Prescribed Melatonin or Ramelteon.
Romero N; Dube KM; Lupi KE; DeGrado JR
Ann Pharmacother; 2021 Nov; 55(11):1347-1354. PubMed ID: 33715466
[TBL] [Abstract][Full Text] [Related]
10. The role of suvorexant in the prevention of delirium during acute hospitalization: A systematic review.
Adams AD; Pepin MJ; Brown JN
J Crit Care; 2020 Oct; 59():1-5. PubMed ID: 32480359
[TBL] [Abstract][Full Text] [Related]
11. Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease: A Retrospective Cohort Study.
Henmi R; Nakamura T; Mashimoto M; Takase F; Ozone M
J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):369-377. PubMed ID: 38820374
[TBL] [Abstract][Full Text] [Related]
12. A Rapid Systematic Review of Pharmacologic Sleep Promotion Modalities in the Intensive Care Unit.
Heavner MS; Louzon PR; Gorman EF; Landolf KM; Ventura D; Devlin JW
J Intensive Care Med; 2024 Jan; 39(1):28-43. PubMed ID: 37403460
[No Abstract] [Full Text] [Related]
13. [Delirium, insomnia in hospitalization and ramelteon].
Ito T
Nihon Rinsho; 2012 May; 70(5):907-13. PubMed ID: 22620020
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study.
Burry L; Scales D; Williamson D; Foster J; Mehta S; Guenette M; Fan E; Detsky M; Azad A; Bernard F; Rose L
BMJ Open; 2017 Mar; 7(3):e015420. PubMed ID: 28363933
[TBL] [Abstract][Full Text] [Related]
15. Suvorexant for the prevention of delirium: A meta-analysis.
Xu S; Cui Y; Shen J; Wang P
Medicine (Baltimore); 2020 Jul; 99(30):e21043. PubMed ID: 32791676
[TBL] [Abstract][Full Text] [Related]
16. Non-pharmacological interventions for sleep promotion in the intensive care unit.
Hu RF; Jiang XY; Chen J; Zeng Z; Chen XY; Li Y; Huining X; Evans DJ
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008808. PubMed ID: 26439374
[TBL] [Abstract][Full Text] [Related]
17. Suvorexant is associated with a low incidence of delirium in critically ill patients: a retrospective cohort study.
Masuyama T; Sanui M; Yoshida N; Iizuka Y; Ogi K; Yagihashi S; Nagatomo K; Sasabuchi Y; Lefor AK
Psychogeriatrics; 2018 May; 18(3):209-215. PubMed ID: 29423967
[TBL] [Abstract][Full Text] [Related]
18. Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU Environment.
Madrid-Navarro CJ; Sanchez-Galvez R; Martinez-Nicolas A; Marina R; Garcia JA; Madrid JA; Rol MA
Curr Pharm Des; 2015; 21(24):3453-68. PubMed ID: 26144941
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic use of exogenous melatonin and melatonin receptor agonists to improve sleep and delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials.
Zhang Q; Gao F; Zhang S; Sun W; Li Z
Sleep Breath; 2019 Dec; 23(4):1059-1070. PubMed ID: 31119597
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
